Kedashiro et al. reported that Nectin-4 and p95-ErbB2 (one of the trastuzumab-resistant HER2 receptor splice variants) cooperatively activated the Hippo signaling-dependent SOX2 gene expression in the T47D serum-free suspension breast cancer cell line. Here, NECTIN4 is linked to breast cancer.